Location History:
- Crosnes, FR (2010 - 2011)
- Paris, FR (2012)
Company Filing History:
2 out of 377 
1 out of 1,454 
1 out of 389 
Years Active: 2010-2012
Title: Luc Bertin: Innovator in Pharmaceutical Chemistry
Introduction
Luc Bertin is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to his name, Bertin's work focuses on innovative drug formulations.
Latest Patents
Bertin's latest patents include "HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof." This invention relates to novel substances that are designed to inhibit the protein chaperone HSP90, which plays a crucial role in cancer cell survival. The compounds are characterized by a complex formula that includes various radicals and heterocycles, making them potential candidates for drug development. Another significant patent is for "Fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90." This patent also focuses on compounds that can be utilized as medicinal products, showcasing Bertin's commitment to advancing therapeutic options.
Career Highlights
Throughout his career, Luc Bertin has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma S.A. and Sanofi. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Bertin has collaborated with esteemed colleagues such as Patrick Mailliet and Jean-Marie Ruxer. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Luc Bertin's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic solutions.